Shandong Weigao repurchases shares, boosting treasury holdings

Shandong Weigao Group Medical Polymer Company Limited (HKEX:1066) reported a share repurchase on November 25, 2025, acquiring 113,200 ordinary H shares through the exchange. This transaction, executed at prices ranging from HK$5.57 to HK$5.59, resulted in an aggregate cost of HK$631,856. The repurchase decreased issued shares (excluding treasury shares) by 113,200, representing 0.0025% of the existing number of issued shares before the event.

Following the repurchase, the company's number of treasury shares increased by 113,200, bringing the closing balance of treasury shares to 26,536,000 as of November 25, 2025. The total number of issued shares remains 4,522,332,324. The company's repurchase mandate, granted on May 27, 2025, authorizes the buyback of up to 451,560,392 shares, of which 19,887,600 shares, or 4.4042% of issued shares at the time of the resolution, have now been repurchased.

A moratorium period for any new share issues or treasury share sales following this repurchase extends up to December 24, 2025. The company confirmed that all repurchases were conducted in accordance with Main Board Rules and that no material changes have occurred since its explanatory statement dated April 30, 2025.